Show simple item record

Measuring quality in arthritis care: the Arthritis Foundation's quality indicator set for analgesics

dc.contributor.authorSaag, Kenneth G.
dc.contributor.authorOlivieri, Jason
dc.contributor.authorPatino, Fausto G.
dc.contributor.authorMikuls, Ted R.
dc.contributor.authorAllison, Jeroan J.
dc.contributor.authorMacLean, Catherine H.
dc.date2022-08-11T08:10:43.000
dc.date.accessioned2022-08-23T17:17:35Z
dc.date.available2022-08-23T17:17:35Z
dc.date.issued2004-06-10
dc.date.submitted2010-08-05
dc.identifier.citationArthritis Rheum. 2004 Jun 15;51(3):337-49. <a href="http://dx.doi.org/10.1002/art.20422">Link to article on publisher's site</a>
dc.identifier.issn0004-3591 (Linking)
dc.identifier.doi10.1002/art.20422
dc.identifier.pmid15188317
dc.identifier.urihttp://hdl.handle.net/20.500.14038/47661
dc.description.abstractOBJECTIVE: To develop systematically validated quality indicators (QIs) addressing analgesic safety. METHODS: A comprehensive literature review of existing quality measures, clinical guidelines, and evidence supporting potential QIs concerning nonselective (traditional) nonsteroidal anti-inflammatory drugs (NSAIDs) and newer cyclooxygenase 2-selective NSAIDs was undertaken. An expert panel then validated or refuted potential indicators utilizing a proven methodology. RESULTS: Eleven potential QIs were proposed. After panel review, 8 were judged to be valid; an additional 10 were proposed by the panel, of which 7 were rated as valid. Quality indicators focused upon informing patients about risk, NSAID choice and gastrointestinal prophylaxis, and side effect monitoring. CONCLUSION: The 15 validated indicators were combined, where appropriate, to yield 10 validated processes of care indicators for the safe use of NSAIDs. These indicators developed by literature review and finalized by our expert panel process can serve as a basis to compare the quality of analgesic use provided by health care providers and delivery systems.
dc.language.isoen_US
dc.relation<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=15188317&dopt=Abstract">Link to Article in PubMed</a>
dc.relation.urlhttp://dx.doi.org/10.1002/art.20422
dc.subjectAnalgesics
dc.subjectAnti-Inflammatory Agents, Non-Steroidal
dc.subjecteffects
dc.subjectArthritis
dc.subjectCyclooxygenase Inhibitors
dc.subjectGastrointestinal Diseases
dc.subjectHumans
dc.subjectPopulation Surveillance
dc.subjectPractice Guidelines as Topic
dc.subjectQuality Indicators, Health Care
dc.subjectRisk Factors
dc.subjectSafety
dc.subjectBioinformatics
dc.subjectBiostatistics
dc.subjectEpidemiology
dc.subjectHealth Services Research
dc.titleMeasuring quality in arthritis care: the Arthritis Foundation's quality indicator set for analgesics
dc.typeJournal Article
dc.source.journaltitleArthritis and rheumatism
dc.source.volume51
dc.source.issue3
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/qhs_pp/789
dc.identifier.contextkey1426263
html.description.abstract<p>OBJECTIVE: To develop systematically validated quality indicators (QIs) addressing analgesic safety.</p> <p>METHODS: A comprehensive literature review of existing quality measures, clinical guidelines, and evidence supporting potential QIs concerning nonselective (traditional) nonsteroidal anti-inflammatory drugs (NSAIDs) and newer cyclooxygenase 2-selective NSAIDs was undertaken. An expert panel then validated or refuted potential indicators utilizing a proven methodology.</p> <p>RESULTS: Eleven potential QIs were proposed. After panel review, 8 were judged to be valid; an additional 10 were proposed by the panel, of which 7 were rated as valid. Quality indicators focused upon informing patients about risk, NSAID choice and gastrointestinal prophylaxis, and side effect monitoring.</p> <p>CONCLUSION: The 15 validated indicators were combined, where appropriate, to yield 10 validated processes of care indicators for the safe use of NSAIDs. These indicators developed by literature review and finalized by our expert panel process can serve as a basis to compare the quality of analgesic use provided by health care providers and delivery systems.</p>
dc.identifier.submissionpathqhs_pp/789
dc.contributor.departmentDepartment of Quantitative Health Sciences
dc.source.pages337-49


This item appears in the following Collection(s)

Show simple item record